Parkman Healthcare Partners Llc

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value
$969.6M
Q ending 2026-03-31
Prior quarter
$1.05B
Q ending 2025-12-31
Change
-7.7% QoQ · +15.0% YoY
Positions
90
reported holdings

Largest positions

All 90 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
HoldingTickerTypeValueShares
Stryker CorporationSYKShares$50.9M155K
Dexcom IncDXCMShares$43.3M690K
Kalvista Pharmaceuticals Inc4XC1Shares$36.9M1.8M
Insulet CorpPODDShares$32.9M157K
Eli Lilly & CoLLYShares$31.8M35K
Ptc Therapeutics IncPTCTShares$29.4M431K
Xenon Pharmaceuticals IncXENEShares$28.9M497K
Boston Scientific CorpBSXShares$28.2M449K
Cvs Health CorpCVSShares$27.8M387K
Arcus Biosciences IncRCUSShares$26.1M1.2M
Livanova PlcShares$25.7M404K
Zimmer Biomet Holdings IncZBHShares$24.4M270K
Mbx Biosciences IncMBXShares$23.9M800K
Ani Pharmaceuticals IncANIPShares$21.6M281K
Syndax Pharmaceuticals IncSNDXShares$21.1M902K
Qiagen NvShares$20.0M500K
Envista Holdings CorporationNVSTShares$18.1M712K
Eyepoint IncEYPTShares$17.5M1.4M
Abbvie IncABBVShares$16.3M75K
Biocryst Pharmaceuticals IncBCRXShares$16.3M1.7M
Iqvia Hldgs IncIQVShares$14.8M87K
Agios Pharmaceuticals IncAGIOShares$13.7M404K
Illumina IncILMNShares$13.6M110K
Edwards Lifesciences CorpEWShares$13.4M167K
Neurocrine Biosciences IncNBIXShares$13.1M99K
Kiniksa Pharmaceuticals IntlShares$12.5M259K
Assembly Biosciences IncASMBShares$11.4M411K
Structure Therapeutics IncGPCRShares$11.2M232K
Mckesson CorpMCKShares$11.0M13K
Stoke Therapeutics IncSTOKShares$11.0M337K
Viridian Therapeutics IncVRDNShares$10.9M558K
Waystar Hldg CorpWAYShares$10.7M443K
Mineralys Therapeutics IncMLYSShares$10.3M380K
Edgewise Therapeutics IncEWTXShares$10.2M323K
Xeris Biopharma Holdings IncXERSShares$10.0M1.7M
Tenet Healthcare CorpTHCShares$9.5M50K
Artivion IncAORTShares$9.2M252K
Nuvalent Inc5AXShares$9.0M88K
Alphatec Hldgs IncATECShares$9.0M824K
Alnylam Pharmaceuticals IncALNYShares$8.9M27K
Axogen IncAXGNShares$8.9M268K
Immunome IncIMNMShares$8.8M403K
Amylyx Pharmaceuticals IncAMLXShares$8.6M621K
Idexx Labs IncIDXXShares$8.4M15K
Waters CorpWATShares$7.9M26K
Adaptive Biotechnologies CorADPTShares$7.7M552K
Upstream Bio IncUPBShares$7.1M787K
Erasca IncERASShares$6.6M407K
Apogee Therapeutics IncAPGEShares$6.5M78K
Cooper Cos IncCOOShares$6.4M90K
Absci CorporationABSIShares$5.6M1.9M
Tango Therapeutics IncTNGXShares$5.6M266K
Moderna IncPut$5.1M100K
Caredx IncCDNAShares$5.1M291K
Urogen Pharma LtdShares$4.9M275K
Ultragenyx Pharmaceutical InRAREShares$4.9M235K
4D Molecular Therapeutics InFDMTShares$4.9M523K
Irhythm Holdings IncIRTCShares$4.7M40K
Minimed Group IncMMEDShares$4.7M317K
Si Bone IncSIBNShares$4.7M374K
Carlsmed IncCARLShares$4.7M521K
Optimizerx CorpOPRXShares$4.6M729K
Vir Biotechnology IncVIRShares$4.5M500K
Supernus PharmaceuticalsSUPNShares$4.4M85K
Caris Life Sciences IncCAIShares$4.1M230K
Cvrx IncCVRXShares$4.1M430K
Inspiremd IncNSPRShares$3.9M2.4M
Cogent Biosciences IncCOGTShares$3.9M100K
Amneal Pharmaceuticals IncAMRXShares$3.7M301K
Annexon IncANNXShares$3.7M674K
Align Technology IncALGNShares$3.6M21K
Uniqure NvShares$3.4M207K
Genedx Holdings CorpWGSShares$3.3M51K
Veracyte IncVCYTShares$3.3M101K
Castle Biosciences IncCSTLShares$3.1M126K
Compass Pathways PlcCMPSShares$3.1M554K
Bright Minds Biosciences IncDRUGShares$2.9M40K
Solid Biosciences IncSLDBShares$2.2M309K
Butterfly Network IncBFLYShares$2.2M544K
Quidelortho CorpQDELShares$1.7M102K
Rxsight IncRXSTShares$1.5M250K
Quanterix CorpQTRXShares$1.2M341K
Pulse Biosciences IncPLSEShares$1.1M50K
Pulmonx CorpLUNGShares$975K756K
Maze Therapeutics IncMAZEShares$951K32K
Adma Biologics IncADMAShares$743K82K
Edap Tms S AFOCLShares$576K155K
Ovid Therapeutics IncOVIDShares$462K208K
Accuray Inc DelARAYShares$343K885K
Entera Bio LtdShares$320K289K

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.